BURROWS FRANCIS (Chief Scientific Officer) sold 41.3% of their position (23.73K shares) of KURA ONCOLOGY, INC. on the open market
Open‑market sale worth $231.9K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/19/2025ACC: 0001193125-25-326948
Officer· Chief Scientific Officer
Since Jan 2026
-23.73K
Net shares
Net seller
$231.9K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
35K acquired · 58.73K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+35K
Price / share
$4.80
Trade value
$168K
% of position
155.8%
12/18/2025
22.46K→57.46K
Common Stock
Direct
Shares
−23.73K
Price / share
$9.78
Trade value
$231.93K
% of position
41.3%
12/18/2025
57.46K→33.73K
Total
Net shares
+11.27K
Net value
-$63.93K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/18/2025 | M · Option Exercise | +35K | $4.80 | $168K | 155.8% | 22.46K | 57.46K |
| Common Stock Direct | 12/18/2025 | S · Sale | −23.73K | $9.78 | $231.93K | 41.3% | 57.46K | 33.73K |
| Total | +11.27K | -$63.93K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common stock
35K shares
Shares
−35K
Strike price
4.8
Held after
0.00
Exercisable
—
12/18/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common stock35K shares | 12/18/2025 | M · Option Exercise | −35K | 4.8 | — | 0.00 |